MedPath
NMPA Approval

Levosimendan Injection

国药准字H20249838

December 25, 2024

Drug Information

左西孟旦注射液

注射剂

5ml:12.5mg

化学药品

December 25, 2024

Company Information

Applicant Company

海口国家高新区药谷工业园二期内

Manufacturing Company

海口国家高新区药谷工业园二期内

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

左西孟旦注射液 - NMPA 批准文号 | MedPath